Skip to main content
SpringerLink
Log in

Adherence to Practice Guidelines for People with Diabetes Mellitus

  • Chapter
Type 2 Diabetes Mellitus

Part of the book series: Contemporary Endocrinology ((COE))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. CDC National Diabetes Fact Sheet, United States 2005. U.S. Department of Health and Human Services Centers for Disease Control and Prevention Website. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf Accessed Sept. 10, 2006.

    Google Scholar 

  2. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917–932.

    Article  PubMed  Google Scholar 

  3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.

    Article  Google Scholar 

  4. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–117.

    Google Scholar 

  5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853.

    Article  Google Scholar 

  6. Nathan DM, Cleary PA, Backlund JY, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643–2653.

    Google Scholar 

  7. Stratton IM, Adler AI, Beil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000;321:405–412.

    Article  CAS  Google Scholar 

  8. Gray A, Raikou M, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. Br Med J 2000;320:1373–1378.

    Article  CAS  Google Scholar 

  9. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA 2001;285:182–189.

    Article  PubMed  CAS  Google Scholar 

  10. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 1998;280:1490–1496.

    Article  PubMed  CAS  Google Scholar 

  11. Vijan S, Hayward RA; American College of Physicians. Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med 2004;140:650–658.

    Google Scholar 

  12. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410–418.

    Article  PubMed  CAS  Google Scholar 

  13. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J 1998;317:713–720.

    Google Scholar 

  14. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383–393.

    Article  PubMed  Google Scholar 

  15. Standards of Medical Care in Diabetes – 2008. American Diabetes Association. Diabetes Care 2008;31(Suppl 1):S12–S54.

    Article  Google Scholar 

  16. AACE Diabetes Guidelines. Endocr Pract 2007;13(suppl 1).

    Google Scholar 

  17. AACE Hypertension Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of hypertension. Endocr Pract 2006 Mar-Apr;12(2):193–222.

    Google Scholar 

  18. AACE Lipid Guidelines Committee. The American Association of Clinical Endocrinologists. AACE medical guilddlines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. Endocr Pract 2000 Mar-Apr;6(2):162–213.

    Google Scholar 

  19. Snow V, Aronson MD, Hornbake ER, Mottur-Pilson C, Weiss KB; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Lipid Control in the Management of Type 2 Diabetes Mellitus: A Clinical Practice Guideline from the American College of Physicians Ann Intern Med 2004;140:644–649.

    PubMed  Google Scholar 

  20. Vijan S, Hayward RA. Treatment of hypertension and setting priorities in diabetes care. Ann Intern Med 2003;138:593–602.

    PubMed  Google Scholar 

  21. Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin Alc targets. A guidance statement from the American College of Physicians. Ann Intern Med 2007;147:417–422.

    PubMed  Google Scholar 

  22. Chobanian AV, Bakris GL, Black HR, et al. National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–1252.

    Article  PubMed  CAS  Google Scholar 

  23. NCEP/ATPIII 2004 Update. Circulation 2004;110:227–239.

    Google Scholar 

  24. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population: National Health and Nutrition Examination Survey 1999–2002. Diabetes Care 2006;29:1263–1268.

    Google Scholar 

  25. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann Intern Med 2006;144:465–474.

    PubMed  Google Scholar 

  26. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335–342.

    Article  PubMed  CAS  Google Scholar 

  27. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004;27:17–20.

    Article  PubMed  Google Scholar 

  28. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Annual Survey Data and Documentation. Available at: http://www.cdc.gov/brfss/ Accessed Sept. 21, 2006.

    Google Scholar 

  29. Hoerger TJ, Segel JE, Gregg EW, Saadine JB. Is glycemic control improving in U.S. adults? Diabetes Care 2008;31:81–86.

    Article  PubMed  Google Scholar 

  30. State of Diabetes in America: a comprehensive report issued by the American Association of Clinical Endocrinologists. Available at: http://www.aace.com/public/awareness/stateofdiabetes/DiabetesAmericaReport.pdf Accessed Sept. 21, 2006.

    Google Scholar 

  31. Andros V, Egger A, Dua U. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes. J Manag Care Pharm 2006;12:303–309.

    PubMed  Google Scholar 

  32. Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis 2005;46:1080–1087.

    Article  PubMed  Google Scholar 

  33. Institute of Medicine of the National Academies. Crossing the Quality Chasm: A New Health System for the 21st Century (2001), executive summary. Available at: http://www.iom.edu/?id=12736 Accessed Sept. 10, 2006.

    Google Scholar 

  34. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002;288:1909–1914.

    Article  PubMed  Google Scholar 

  35. Sequist TD, Gandhi TK, Karson AS, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc 2005;12:431–437.

    Article  PubMed  Google Scholar 

  36. National Diabetes Education Program. Making Systems Changes for Better Diabetes Care. Available at: www.betterdiabetescare. nih.gov Accessed Sept. 10, 2006.

    Google Scholar 

  37. Meigs JB, Cagliero E, Dubey A, et al. A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care 2003;26:750–757.

    Article  PubMed  Google Scholar 

  38. O’Conner PJ. Electronic medical records and diabetes care improvement: are we waiting for Godot? Diabetes Care 2003;26:942–943.

    Article  Google Scholar 

  39. Montori VM, Dinneen SF, Gorman CA, et al. The impact of planned care and a diabetes electronic management system on community-based diabetes care: the Mayo Health System Diabetes Translation Project. Diabetes Care 2002;25:1952–1957.

    Article  PubMed  Google Scholar 

  40. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002;288:1723–1727.

    Article  PubMed  Google Scholar 

  41. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990–1998. Diabetes Care 2000;23:1278–1283.

    Article  PubMed  CAS  Google Scholar 

  42. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218–1224.

    Article  PubMed  Google Scholar 

  43. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836–1841.

    Article  PubMed  Google Scholar 

  44. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med 2006;166:1802–1804.

    Article  Google Scholar 

  45. Rubin RR, Peyrot M, Siminerio LM. Health care and patient-reported outcomes: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care 2006;29:1249–1255.

    Article  PubMed  Google Scholar 

  46. Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care 2005;28:626–631.

    Article  PubMed  Google Scholar 

  47. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem . Diabetes Care 2005;28:2543–2545.

    Article  PubMed  Google Scholar 

  48. United Kingdom Prospective Diabetes Study Group. United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. Br Med J 1995;310:83–88.

    Google Scholar 

  49. Polonsky WH, Jackson RA. What’s so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clinical Diabetes 2004;22:147–150.

    Article  Google Scholar 

  50. Fonseca VA, ed. Clinical Diabetes: Translating Research into Practice – 1st ed. Saunders Elsevier, Philadelphia, PA; 2006.

    Google Scholar 

  51. Blonde L, Parkin MS. Internet Resources to Improve Health Care for Patients with Diabetes. Endocr Pract 2006; 12(suppl 1) January/February.

    Google Scholar 

  52. American Diabetes Association. Diabetes PHD (Personal Health Decisions). Available at: https://www.diabetes.org/phd/ profile/default.jsp Accessed Sept. 22, 2006.

    Google Scholar 

  53. Blonde L, Karter AJ. Current evidence regarding the value of self-monitored blood glucose testing. Am J Med 2005;118(Suppl 9A):20S–26S.

    Article  PubMed  Google Scholar 

  54. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004;27:1535–1540.

    Article  PubMed  Google Scholar 

  55. Boyd CM, Leff B. Quality of care for older patients with diabetes mellitus with comorbidity. J Am Geriatr Soc 2006;54:553–554; author reply 554.

    Article  PubMed  Google Scholar 

  56. Peyrot M, Rubin RR, Lauritzen T, et al.; The International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673–2679.

    Article  PubMed  Google Scholar 

  57. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obesity 2002;26(Suppl 3):S18–S24.

    Article  CAS  Google Scholar 

  58. ACE/AACE Diabetes Road Map Task Force. Road Map for the prevention and treatment of type 2 diabetes. Available at: http://www.aace.com/meetings/consensus/odimplementation/roadmap.pdf Accessed Jan. 13, 2008.

    Google Scholar 

  59. Nathan DM, Buse JB, Davison MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29:1963–1972.

    Article  PubMed  Google Scholar 

  60. Texas Department of State Health Services: Texas Diabetes Council. Minimum Standards for Diabetes Care in Texas. Available at: http://www.dshs.state.tx.us/diabetes/hcstand.shtm Accessed Sept. 22, 2006.

    Google Scholar 

  61. The National Diabetes Quality Improvement Alliance Performance Measurement Set for Adult Diabetes. Available at: http://www.nationaldiabetesalliance.org/Final2005Measures.pdf Accessed Sept. 12, 2006.

    Google Scholar 

  62. National Committee for Quality Assurance (NCQA). Bridges to Excellence: Rewarding Quality across the Healthcare System. Available at: http://www.ncqa.org/Programs/bridgestoexcellence/bridgesq-a.htm Accessed Sept. 16, 2006.

    Google Scholar 

  63. Mahoney JJ. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care 2005;11(5 Suppl):S170–176.

    PubMed  Google Scholar 

Download references

Authors
  1. Marideli Colón Scanlan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence Blonde
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Duke University Medical Center Durham, NC, USA

    Mark N. Feinglos MD, CM  & M. Angelyn Bethel MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Scanlan, M.C., Blonde, L. (2008). Adherence to Practice Guidelines for People with Diabetes Mellitus. In: Feinglos, M.N., Bethel, M.A. (eds) Type 2 Diabetes Mellitus. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-60327-043-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-043-4_15

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-794-5

  • Online ISBN: 978-1-60327-043-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation